Whitepapers

For small and emerging biopharmas, GxP compliance often becomes more challenging as development efforts expand. A sponsor may begin with a relatively small team and

For small and emerging biopharmas, expanding a clinical trial beyond the United States can be an important step toward reaching more patients and supporting future

At many biopharmaceutical organizations, audit readiness becomes a priority only when an inspection is on the calendar. As the countdown begins, teams review documentation, verify

Managing a modern clinical trial can feel a bit like herding cats. Every vendor brings specialized expertise, but each also has its own processes, priorities,

Despite the clinical trial industry’s rapid transformation over the last decade, the fundamentals of the Trial Master File (TMF) haven’t changed. Regulators still expect a

Clinical development teams are under increasing pressure from multiple directions, and it’s starting to change how their work gets done. While outsourcing was once a